The Revaluation of Plant-Derived Terpenes to Fight Antibiotic-Resistant Infections
-
Microbes
Microbes
Microbes, short for microorganisms, are tiny living organisms that are ubiquitous in the environment, including on and inside the human body. They play a crucial role in human health and disease, functioning within complex ecosystems in various parts of the body, such as the skin, mouth, gut, and respiratory tract. The human microbiome, which is […]
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
Karen Pendergrass
What was studied?
The study focused on terpenes derived from plants as potential antimicrobial agents, particularly their effectiveness against antibiotic-resistant infections. This included an exploration of the diverse mechanisms by which terpenes combat microbial resistance, their bioavailability, and the synergistic effects when combined with other antimicrobials.
Who was studied?
The research mainly involved microbial organisms that are known to exhibit resistance to conventional antibiotics. This included a variety of pathogens such as Gram-positive and Gram-negative bacteria, with specific attention to multi-drug resistant strains.
What were the most important findings?
The study found that plant-derived terpenes have significant antimicrobial activity against resistant strains. It highlighted the mechanisms of action of terpenes, such as disruption of microbial membranes, inhibition of biofilm formation, and efflux pump inhibition. These findings suggest terpenes’ potential as effective agents in combating antibiotic-resistant infections.
What are the greatest implications of this study?
The implications are substantial in the context of global health challenges posed by antibiotic resistance. The findings suggest that terpenes could be developed into new antimicrobial agents that offer a viable alternative to traditional antibiotics. This could lead to the development of novel therapeutic strategies and formulations, potentially reducing the prevalence of resistant infections and the healthcare burdens associated with them.